Related Experiment Video
Updated: Jun 21, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Antithrombotic strategies in patients on oral anticoagulant therapy undergoing percutaneous coronary intervention: a
Giuseppe Patti1, Germano Di Sciascio
1Department of Cardiovascular Sciences, Campus Bio-Medico University of Rome, Via Alvaro del Portillo, Rome, Italy.
Insights
Patients on oral anticoagulants needing percutaneous coronary intervention require tailored antithrombotic strategies. This review addresses the lack of guidelines for optimal post-procedure treatment to balance bleeding and ischemic risks.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Growing number of patients on chronic oral anticoagulation therapy undergoing percutaneous coronary intervention (PCI).
- Absence of evidence-based data and practice guidelines for optimal antithrombotic treatment post-PCI in this population.
- Variable and physician-dependent strategies currently employed.
Purpose of the Study:
- To review current evidence regarding antithrombotic strategies for patients on oral anticoagulation undergoing PCI.
- To propose a patient-tailored algorithm for post-PCI antithrombotic management.
- To balance the risks of bleeding, ischemic complications, and thromboembolism.
Main Methods:
- Review of existing scientific literature on antithrombotic therapy in patients on oral anticoagulation undergoing PCI.
- Development of a clinical decision-making algorithm based on risk stratification.
- Consideration of bleeding risk, ischemic events, and thromboembolic potential.
Main Results:
- Current evidence is limited, leading to heterogeneous clinical practices.
- An individualized approach is necessary to optimize antithrombotic therapy.
- The proposed algorithm aims to guide physicians in selecting appropriate strategies.
Conclusions:
- There is a critical need for evidence-based guidelines for managing antithrombotic therapy post-PCI in patients on oral anticoagulation.
- A tailored, risk-stratified approach is essential for effective patient management.
- Further research is warranted to establish definitive treatment protocols.
Abstract:
An increasing number of patients on chronic oral anticoagulant therapy undergo percutaneous coronary intervention. There is a lack of evidence-based data and no practice guidelines are available about the optimal antithrombotic treatment of such patients after the procedure; thus, the adopted strategies are highly variable and are often left to the discretion of the attending physician. In this article, we review current evidence and propose an algorithm of antithrombotic strategies tailored to the individual patient, which takes into account the relative risks of bleeding, ischemic complications, and thromboembolism.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Acute Coronary Syndrome IV: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Coronary Artery Disease V: Interprofessional Care